$IBO News

Impact BioMedical Q1 EPS $(0.02) Up From $(0.11) YoY, Sales $7.000K

Reported Friday, Impact BioMedical Reports Going Concern Audit Opinion For Fiscal Year 2025 While Continuing Strategic Merger Plans With Dr. Ashley's Ltd.

Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans

Unusual volume stocks are being observed in Thursday's session.

Impact Biomedical (IBO) Stock Jumps Over 86% After Hours — Here's Why

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue

Impact BioMedical Q2 EPS $(1.18), Sales $7.00K

Impact BioMedical Stock Is Soaring Monday: What's Going On?

Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger

Impact BioMedical shares are trading higher after the company announced a limited merger and share exchange agreement with Dr Ashleys.

Impact BioMedical And Dr Ashleys Limited Announce Merger And Share Exchange Agreement; Dr. Ashleys To Acquire Impact BioMedical Through A Reverse Merger

Dr Ashleys to Go Public via Merger With Impact BioMedical in NYSE Deal

Impact BioMedical Shares Resume Trade

Impact BioMedical Shares Resume Trade Then Again Halted On Circuit Breaker To The Downside, Stock Now Down -42.4%

Impact BioMedical Shares Halted On Circuit Breaker To The Downside, Stock Now Down -30%

Impact Biomedical Inc. Announcement Stock Activity/Pricing

Impact Biomedical Says 'There Has Been No Material Development In Its Business Affairs Not Previously Disclosed Or, To Its Knowledge, Any Other Reason To Account For The Unusual Market Action Regarding Its Share Price'

Why Impact Biomedical Inc. (IBO) Surged On Thursday?

Impact BioMedical Shares Resume Trade Then Halted On Circuit Breaker To The Downside, Stock Now Up 301.9%

Impact BioMedical Shares Resume Trade Then Again Halt On Circuit Breaker To The Upside, Stock Now Up 311.3%